Simultaneous quantification of cilostazol and its primary metabolite 3,4-dehydrocilostazol in human plasma by rapid liquid chromatography/tandem mass spectrometry

Analytical and Bioanalytical Chemistry

Volumn 384, Issue 3, 2006, Pages 780-790

  Nirogi, Ramakrishna V S ^a   Kandikere, Vishwottam N ^a   Shukla, Manoj ^a   Mudigonda, Koteshwara ^a   Shrivasthava, Wishu ^a   Datla, Praveen V ^a   Yerramilli, Anjaneyulu ^b  

^a SUVEN LIFE SCIENCES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

3,4 Dehydrocilostazol; Cilostazol; Human plasma; Liquid chromatography tandem mass spectrometry; Pharmacokinetics study

Indexed keywords

3,4-DEHYDROCILOSTAZOL; CILOSTAZOL; HUMAN PLASMA; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; PHARMACOKINETICS STUDY;

BIOASSAY; ETHERS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PHARMACOKINETICS;

ALCOHOLS;

3,4 DEHYDROCILOSTAZOL; 3,4-DEHYDROCILOSTAZOL; CILOSTAZOL; TETRAZOLE DERIVATIVE;

ARTICLE; BLOOD; CHEMICAL STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TIME;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MOLECULAR STRUCTURE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TETRAZOLES; TIME FACTORS;

EID: 32544449325     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-005-0198-z     Document Type: Article

References (25)

1. Reilly MP, Mohler ER III (2001) Ann Pharmacother 35:48-56
2. Sorkin EM, Markham A (1999) Drugs Aging 14:63-71
3. Jacoby D, Mohler ER III (2004) Drugs 64:1657-1670
4. Bramer SL, Forbes WP (1999) Clin Pharmacokinet 37 Suppl 2:13-23
5. Bramer SL, Forbes WP, Mallikaarjun S (1999) Clin Pharmacokinet 37 Suppl 2:1-11
6. Akiyama H, Kudo S, Shimizu T (1985) Arznei-Forsch 35:1133-1140
7. Akiyama H, Kudo S, Odomi M, Shimizu T (1985) J Chromatogr 338:456-459
8. Tata PN, Fu CH, Brower NJ, Chow PC, Bramer SL (1998) J Pharm Biomed Anal 18:441-451
9. Tata PN, Fu CH, Bramer SL (2001) J Pharm Biomed Anal 24:381-389
10. Fu CJ, Tata PNV, Okada K, Akiyama H, Bramer SL (1999) J Chromatogr B 728:251-262
11. Jemal M (2000) Biomed Chromatogr 14:422
12. Ramakrishna NVS, Koteshwara M, Vishwottam KN, Puran S, Manoj S, Santosh M (2004) J Pharm Biomed Anal 36:505-515
13. Ramakrishna NVS, Vishwottam KN, Puran S, Koteshwara M, Manoj S, Santosh M (2004) J Chromatogr B 809:117-124
14. Ramakrishna NVS, Vishwottam KN, Puran S, Koteshwara M, Manoj S, Santosh M (2004) J Chromatogr B 809:243-249
15. Ramakrishna NVS, Vishwottam KN, Puran S, Manoj S, Santosh M, Koteshwara M (2004) J Mass Spectrom 39:824-832
16. Ramakrishna NVS, Vishwottam KN, Puran S, Manoj S, Santosh M, Wishu S, Koteshwara M (2004) J Chromatogr B 805:13-20
17. Ramakrishna NVS, Vishwottam KN, Manoj S, Koteshwara M, Chidambara J, Varma DP (2005) Biomed Chromatogr 19:539-548
18. Ramakrishna NVS, Vishwottam KN, Puran S, Koteshwara M, Manoj S, Santosh M, Varma DP (2005) J Pharm Biomed Anal 39:1006-1013
19. Ramakrishna NVS, Vishwottam KN, Manoj S, Koteshwara M, Santosh M, Chidambara J, Ravi Kumar B (2005) Rapid Commun Mass Spectrom 19:1970-1978
20. Cech NB, Enke CG (2001) Mass Spectrom Rev 20:362-387
21. Niessen WM (2003) J Chromatogr A 1000:413-436
22. Lee MS, Kerns EH (1999) Mass Spectrom Rev 18:187-279
23. Nirogi RVS, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Boosi R, Yerramilli A (2005) Anal Chim Acta DOI 10.1016/j.aca.2005.08.007
24. Bramer SL, Tata PNV, Vevgurlekar SS, Brisson JH (2001) J Pharm Biomed Anal 26:637-650
25. US Department of Health and Human Services(2001) Guidance for industry: bioanalytical method validation., Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD